Both in Pharmaceuticals
Climb Bio vs Crescent Biopharma
Over the past year CLYM returned +319.5% and CBIO returned −1.8%; their daily moves had a correlation of 0.22.
CLYM +319.5% CBIO −1.8%Growth of $1, one year, split-adjusted
| Metric | CLYM | CBIO |
|---|---|---|
| Price | $8.81 | $12.76 |
| Market cap | $506.0M | $474.0M |
| Today | −13.54% | −0.47% |
| 1 month | −24.4% | −8.8% |
| 6 months | −7.3% | −49.3% |
| Year to date | +120.3% | +7.6% |
| 1 year | +342.7% | −0.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 39.9× |
| Net cash | $183.1M | $171.6M |
| Dividend yield | — | — |
| Volatility (60d) | 82.1% | 71.4% |
| Short % of float | 25.6% | 21.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).